Clinical trials
Phase 2 Leukemia, Myeloid, Acute trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| OncoVerity, Inc. | 2 |
| Cogent Biosciences, Inc. | 1 |
| ETH Zurich | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Swiss Cancer Institute | 1 |
| University Medical Center Groningen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 9 |
| Leukemia | 4 |
| Congenital Abnormalities | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Myeloproliferative Disorders | 2 |
| Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Ataxia Telangiectasia | 1 |
| Blast Crisis | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.